84-2173-59 [取扱停止]CDKN1C (Cyclin-dependent Kinase Inhibitor 1C, BWCR, BWS, KIP2, WBS, p57) 50ul 210077

※お見積書はカートで印刷できます

冷凍 保管・搬送時に冷凍が必要な商品です。

特徴

  • p27 Kip1 is a member of the Cip/Kip family of cyclin-dependent kinase inhibitors.
  • Like its relatives, p57 Kip2 and p21 Waf1/Cip1, the ability to enforce the G1 restriction point is derived from its inhibitory binding to CDK2/cyclin E and other CDK/cyclin complexes.
  • Expression levels of p27 are upregulated in quiescent cells and in cells treated with cAMP or other negative cell cycle regulators.
  • Downregulation of p27 can be induced by treatment with interleukin-2 or other mitogens; this involves phosphorylation of p27 and its degradation by the ubiquitin-proteasome pathway (1-4)
  • p57 Kip2 (Cyclin-dependent kinase inhibitor 1C) functions as a tumor suppressor.
  • Mutations of p57 Kip2 have been associated with numerous human malignancies as well as Beckwith–Wiedemann syndrome (BWS), characterized by an increased risk of childhood cancer.
  • The amino-terminal CDK inhibitory domain, common to the family, binds to and inhibits CDK/cyclin complexes and restricts cell cycle progression (5).
  • The unique central region of p57 Kip2 interactes with LIMK-1, a downstream effector of the Rho family of GTPases.
  • By sequestering LIMK-1 in the nucleus, p57 Kip2 disrupts actin dynamics within cells and may be linked to its essential role in embryonic development (6).
  • In addition, the carboxyl-terminal QT domain of p57KIP2 binds to and inhibits JNK/SAPK activity regulating cellular apoptosis and differentiation (7).
  • Expression levels of human p57 Kip2 are more restricted then other CDK inhibitors (8) and are controlled by ubiquitination/degradation via the Skp1/Cul1/F-box-type E3 ubiquitin ligase complex SCF-Skp2.
  • This effect is dependent on Thr310 (9).
  • A similar threonine phosphorylation site in p27 Kip1, Thr187, has also been shown to regulate protein stability (10).
  • Applications:Suitable for use in Western Blot.
  • Other applications not tested.
  • Recommended Dilution:Western Blot: 1:500-1:2000Optimal dilutions to be determined by the researcher.
  • Storage and Stability:May be stored at 4°C for short-term only.
  • Aliquot to avoid repeated freezing and thawing.
  • Store at -20°C.
  • Aliquots are stable for 12 months after receipt.
  • For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

仕様

  • Size:50ul
  • Host:rabbit
  • Source Antibody:human
  • Grade:Affinity Purified
  • Purity:Purified by affinity chromatography.
  • Form:Supplied as a liquid in PBS, pH 7.3, 0.02% sodium azide, 50% glycerol.
  • Specificity:Recognizes human CDKN1C.
  • Isotype:IgG
  • Calc Applications Abbrev:WB
  • Calc Crossreactivity:Hu
  • Immunogen:Synthetic peptide corresponding to human CDKN1C.
  • Shelf Life:1year
  • Swiss Prot Number:P49918
  • EU Commodity Code:30021010
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
84-2173-59
型番
210077
入り数
1個
標準価格
108,000円(税抜)
WEB価格
取扱停止
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る